Search

Raymond J. Henley Iii

Examiner (ID: 7179, Phone: (571)272-0575 , Office: P/1629 )

Most Active Art Unit
1614
Art Unit(s)
1205, 2899, 1629, 1614, 1621
Total Applications
4324
Issued Applications
3034
Pending Applications
603
Abandoned Applications
710

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7436836 [patent_doc_number] => 20040002502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Medicament combinations comprising heterocyclic compounds and a novel anticholinergic' [patent_app_type] => new [patent_app_number] => 10/409402 [patent_app_country] => US [patent_app_date] => 2003-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12726 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002502.pdf [firstpage_image] =>[orig_patent_app_number] => 10409402 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/409402
Medicament combinations comprising heterocyclic compounds and a novel anticholinergic Apr 7, 2003 Abandoned
Array ( [id] => 6830472 [patent_doc_number] => 20030181530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Soluble compositions of triphenylethylene antiestrogens' [patent_app_type] => new [patent_app_number] => 10/408321 [patent_app_country] => US [patent_app_date] => 2003-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3862 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20030181530.pdf [firstpage_image] =>[orig_patent_app_number] => 10408321 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/408321
Soluble compositions of triphenylethylene antiestrogens Apr 7, 2003 Issued
Array ( [id] => 7136296 [patent_doc_number] => 20040044004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Calcium channel inhibitors comprising benzhydril spaced from piperazine' [patent_app_type] => new [patent_app_number] => 10/409868 [patent_app_country] => US [patent_app_date] => 2003-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9635 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20040044004.pdf [firstpage_image] =>[orig_patent_app_number] => 10409868 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/409868
Calcium channel inhibitors comprising benzhydril spaced from piperazine Apr 7, 2003 Issued
Array ( [id] => 1009457 [patent_doc_number] => 06900219 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-31 [patent_title] => 'ABCA-1 elevating compounds' [patent_app_type] => utility [patent_app_number] => 10/407875 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18531 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/900/06900219.pdf [firstpage_image] =>[orig_patent_app_number] => 10407875 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/407875
ABCA-1 elevating compounds Apr 3, 2003 Issued
Array ( [id] => 7387393 [patent_doc_number] => 20040029907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Powder formulations containing tiotropium suitable for inhalation' [patent_app_type] => new [patent_app_number] => 10/406723 [patent_app_country] => US [patent_app_date] => 2003-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3997 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029907.pdf [firstpage_image] =>[orig_patent_app_number] => 10406723 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/406723
Powder formulations containing tiotropium suitable for inhalation Apr 2, 2003 Issued
Array ( [id] => 6730854 [patent_doc_number] => 20030187044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Medicament' [patent_app_type] => new [patent_app_number] => 10/404345 [patent_app_country] => US [patent_app_date] => 2003-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11842 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20030187044.pdf [firstpage_image] =>[orig_patent_app_number] => 10404345 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/404345
Medicament Mar 31, 2003 Abandoned
Array ( [id] => 1071998 [patent_doc_number] => 06841565 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-11 [patent_title] => 'Treatment of patients with chronic lymphocytic leukemia' [patent_app_type] => utility [patent_app_number] => 10/403667 [patent_app_country] => US [patent_app_date] => 2003-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6335 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/841/06841565.pdf [firstpage_image] =>[orig_patent_app_number] => 10403667 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/403667
Treatment of patients with chronic lymphocytic leukemia Mar 30, 2003 Issued
Array ( [id] => 7437391 [patent_doc_number] => 20040002537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Use of statins in the treatment of autoimmune disease' [patent_app_type] => new [patent_app_number] => 10/404922 [patent_app_country] => US [patent_app_date] => 2003-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6629 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002537.pdf [firstpage_image] =>[orig_patent_app_number] => 10404922 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/404922
Use of statins in the treatment of autoimmune disease Mar 30, 2003 Abandoned
Array ( [id] => 7401405 [patent_doc_number] => 20040019036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Treatment of chronic myelogenous leukemia, resistant or intolerant to ST1571, involving homoharringtonine alone or combined with other agents' [patent_app_type] => new [patent_app_number] => 10/397267 [patent_app_country] => US [patent_app_date] => 2003-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10148 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20040019036.pdf [firstpage_image] =>[orig_patent_app_number] => 10397267 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/397267
Treatment of chronic myelogenous leukmia, resistant or intolerant to ST1571, involving homoharringtonine alone or combined with other agents Mar 26, 2003 Issued
Array ( [id] => 679125 [patent_doc_number] => 07083779 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-01 [patent_title] => 'Nontoxic dental care herbal formulation for preventing dental plaque and gingivitis' [patent_app_type] => utility [patent_app_number] => 10/397967 [patent_app_country] => US [patent_app_date] => 2003-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8807 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/083/07083779.pdf [firstpage_image] =>[orig_patent_app_number] => 10397967 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/397967
Nontoxic dental care herbal formulation for preventing dental plaque and gingivitis Mar 25, 2003 Issued
Array ( [id] => 1170012 [patent_doc_number] => 06753350 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-22 [patent_title] => 'Method to reduce the incidence of intraventricular hemorrhage in preterm infants' [patent_app_type] => B1 [patent_app_number] => 10/395356 [patent_app_country] => US [patent_app_date] => 2003-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13644 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/753/06753350.pdf [firstpage_image] =>[orig_patent_app_number] => 10395356 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/395356
Method to reduce the incidence of intraventricular hemorrhage in preterm infants Mar 23, 2003 Issued
Array ( [id] => 6805463 [patent_doc_number] => 20030232857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Chronic, bolus administration of D-threo methylphenidate' [patent_app_type] => new [patent_app_number] => 10/395444 [patent_app_country] => US [patent_app_date] => 2003-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5375 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232857.pdf [firstpage_image] =>[orig_patent_app_number] => 10395444 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/395444
Chronic, bolus administration of D-threo methylphenidate Mar 23, 2003 Abandoned
Array ( [id] => 6639085 [patent_doc_number] => 20030212004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis' [patent_app_type] => new [patent_app_number] => 10/380763 [patent_app_country] => US [patent_app_date] => 2003-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2781 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212004.pdf [firstpage_image] =>[orig_patent_app_number] => 10380763 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/380763
Therapeutic use of aerosolized S-nitrosoglutathione in cystic fibrosis Mar 23, 2003 Issued
Array ( [id] => 7233332 [patent_doc_number] => 20050256086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Fosinopril formulation' [patent_app_type] => utility [patent_app_number] => 10/507918 [patent_app_country] => US [patent_app_date] => 2003-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1161 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256086.pdf [firstpage_image] =>[orig_patent_app_number] => 10507918 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/507918
Fosinopril formulation Mar 18, 2003 Issued
Array ( [id] => 6835283 [patent_doc_number] => 20030162829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Combination of treatment of cancer utilizing a COX-2 inhibitor and a 3-hydroxy-3-methylglutaryl-coenzyme-a (HMG-CoA) reductase inhibitor' [patent_app_type] => new [patent_app_number] => 10/390517 [patent_app_country] => US [patent_app_date] => 2003-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16593 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162829.pdf [firstpage_image] =>[orig_patent_app_number] => 10390517 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/390517
Combination of treatment of cancer utilizing a COX-2 inhibitor and a 3-hydroxy-3-methylglutaryl-coenzyme-a (HMG-CoA) reductase inhibitor Mar 16, 2003 Abandoned
Array ( [id] => 6939720 [patent_doc_number] => 20050113283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Methods of treating conditions associated with an EDG-4 receptor' [patent_app_type] => utility [patent_app_number] => 10/390429 [patent_app_country] => US [patent_app_date] => 2003-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 33675 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113283.pdf [firstpage_image] =>[orig_patent_app_number] => 10390429 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/390429
Methods of treating conditions associated with an EDG-4 receptor Mar 13, 2003 Abandoned
Array ( [id] => 6906123 [patent_doc_number] => 20050101518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Methods of treating conditions associated with an EDG-2 receptor' [patent_app_type] => utility [patent_app_number] => 10/390427 [patent_app_country] => US [patent_app_date] => 2003-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22682 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101518.pdf [firstpage_image] =>[orig_patent_app_number] => 10390427 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/390427
Methods of treating conditions associated with an EDG-2 receptor Mar 13, 2003 Abandoned
Array ( [id] => 5051914 [patent_doc_number] => 20070032459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'METHODS OF TREATING CONDITIONS ASSOCIATED WITH AN EDG-3 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 10/390426 [patent_app_country] => US [patent_app_date] => 2003-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20596 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032459.pdf [firstpage_image] =>[orig_patent_app_number] => 10390426 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/390426
Methods of treating conditions associated with an Edg-3 receptor Mar 13, 2003 Issued
Array ( [id] => 7011493 [patent_doc_number] => 20050065209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Citalopram for the treatment of elevated blood pressure' [patent_app_type] => utility [patent_app_number] => 10/489179 [patent_app_country] => US [patent_app_date] => 2003-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2798 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20050065209.pdf [firstpage_image] =>[orig_patent_app_number] => 10489179 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/489179
Citalopram for the treatment of elevated blood pressure Mar 12, 2003 Issued
Array ( [id] => 961177 [patent_doc_number] => 06951890 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-04 [patent_title] => 'Preventing and/or treating cardiovascular disease and/or associated heart failure' [patent_app_type] => utility [patent_app_number] => 10/388213 [patent_app_country] => US [patent_app_date] => 2003-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 32697 [patent_no_of_claims] => 85 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/951/06951890.pdf [firstpage_image] =>[orig_patent_app_number] => 10388213 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/388213
Preventing and/or treating cardiovascular disease and/or associated heart failure Mar 11, 2003 Issued
Menu